A detailed history of Anfield Capital Management, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Anfield Capital Management, LLC holds 8 shares of ILMN stock, worth $1,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 8 -0.0%
Holding current value
$1,081
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$101.05 - $133.57 $808 - $1,068
8 New
8 $0
Q1 2020

May 07, 2020

SELL
$209.2 - $335.53 $5,857 - $9,394
-28 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$288.29 - $335.49 $8,072 - $9,393
28 New
28 $8,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.3B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Anfield Capital Management, LLC Portfolio

Follow Anfield Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anfield Capital Management, LLC with notifications on news.